cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AJ292190 | .a | 234 to 2414 | 1 to 2181 | tiling clone, | 2181/2182 (99 %) | 1 diff (100.0 %id) | ||
AK123254 | amygdala | .a | 4525 to 6901 | 1 to 2377 | tiling clone, available from FLJ, | 2377/2377 (100 %) | 3 diff (99.9 %id) | |
AK307521 | brain | .a | 52 to 2433 | 1 to 2379 | 2382/2379 (100 %) | 5 diff (99.8 %id) | ||
AK307657 | testis | .a | 50 to 1832 | 1 to 1783 | 1783/1783 (100 %) | 5 diff (99.8 %id) | ||
AL117661 | uterus | .a | 307 to 2325 | 8 to 2026 | available from DKFZ, AAA | 2019/2019 (100 %) | 1 diff (100.0 %id) | |
AW859598 | colon | .a | 930 to 1426 | 1 to 497 | 497/497 (100 %) | 3 diff (99.4 %id) | ||
AW974322 | .a | 1274 to 1823 | 554 to 3 | Submitted on the opposite strand | 552/554 (99 %) | 0 diff (100 %id) | ||
AW977721 | .a | 4247 to 4898 | 653 to 1 | Submitted on the opposite strand | 653/654 (99 %) | 20 diff (97.0 %id) | ||
BF741143 | bocio_tumor | .a | 1776 to 2198 | 1 to 424 | 424/424 (100 %) | 7 diff (98.4 %id) | ||
BG996577 | head_neck | .a | 3403 to 3783 | 23 to 402 | 380/410 (92 %) | 2 diff (99.6 %id) | ||
BI037105 | nervous_tumor | .a | 1770 to 2066 | 307 to 6 | 302/307 (98 %) | 0 diff (100 %id) | ||
BQ321967 | colon | .a | 1662 to 1958 | 303 to 7 | 297/303 (98 %) | 0 diff (100 %id) | ||
BQ325946 | colon_ins | .a | 1383 to 1911 | 535 to 7 | 529/535 (98 %) | 0 diff (100 %id) | ||
DA172142 | amygdala | .a | 4526 to 4829 | 2 to 305 | capped | 304/304 (100 %) | 0 diff (100 %id) | |
DB302620 | amygdala | .a | 6352 to 6901 | 554 to 1 | 554/554 (100 %) | 5 diff (99.1 %id) | ||
DA260330 | caudate nucleus | .a | 50 to 626 | 2 to 579 | capped | 578/578 (100 %) | 1 diff (99.9 %id) | |
DA367770 | subthalamic nucleus | .a | 42 to 585 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | |
BX094325 | .a | 3690 to 4128 | 1 to 439 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 439/439 (100 %) | 0 diff (100 %id) | |
BX113502 | lung | .a | 1508 to 1981 | 1 to 474 | 474/474 (100 %) | 1 diff (99.8 %id) | ||
DA419450 | cord Blood | .a | 30 to 583 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | |
CN394033 | embryonic stem cells, DMSO-treated H9 cellline | .a | 1080 to 1478 | 1 to 400 | 400/400 (100 %) | 3 diff (99.3 %id) | ||
CN394034 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 1002 to 1715 | 1 to 716 | 716/716 (100 %) | 4 diff (99.5 %id) | ||
CN394035 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 76 to 401 | 1 to 326 | 326/326 (100 %) | 0 diff (100 %id) | ||
CN394036 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 413 to 897 | 1 to 485 | 485/485 (100 %) | 0 diff (100 %id) | ||
CR746734 | epithelioid carcinoma, Pancreas | .a | 2523 to 3024 | 4 to 505 | tiling clone, | 502/505 (99 %) | 6 diff (98.9 %id) | |
CA397451 | eye, RPE/choroid | .a | 407 to 955 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | ||
DA465610 | .a | 30 to 601 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
AL042512 | testis | .a | 2944 to 3325 | 437 to 44 | Submitted on the opposite strand | 394/440 (89 %) | 0 diff (100 %id) | |
DN919024 | .a | 1821 to 2120 | 311 to 10 | 302/323 (93 %) | 0 diff (100 %id) | |||
DT217358 | brain | .a | 809 to 1481 | 1 to 672 | 672/672 (100 %) | 6 diff (99.2 %id) | ||
DW461169 | Liver | .a | 4652 to 4765 | 17 to 130 | 114/130 (87 %) | 0 diff (100 %id) | ||
EH336262 | .a | 831 to 902 | 1 to 72 | 72/72 (100 %) | 0 diff (100 %id) | |||
DA511276 | brain | .a | 53 to 609 | 2 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | |
CD672928 | eye, Iris | .a | 1623 to 1754 | 1 to 132 | 132/132 (100 %) | 0 diff (100 %id) | ||
FN064746 | breast carcinoma | .a | 722 to 804 | 1 to 83 | 83/83 (100 %) | 2 diff (97.6 %id) | ||
FN105065 | breast carcinoma | .a | 1509 to 1619 | 1 to 107 | 107/107 (100 %) | 4 diff (96.3 %id) | ||
FN162081 | breast carcinoma | .a | 4790 to 4901 | 1 to 114 | 114/117 (97 %) | 4 diff (96.6 %id) | ||
DB496395 | hypothalamus | .a | 49 to 519 | 1 to 471 | 471/471 (100 %) | 2 diff (99.6 %id) | ||
DB567418 | hypothalamus | .a | 1385 to 1832 | 1 to 448 | Submitted on the opposite strand | 448/448 (100 %) | 1 diff (99.8 %id) | |
BQ639837 | eye, retina | .a | 41 to 586 | 1 to 541 | 541/541 (100 %) | 8 diff (98.6 %id) | ||
BP872677 | embryonal kidney | .a | 29 to 615 | 1 to 587 | 587/587 (100 %) | 4 diff (99.4 %id) | ||
R00290 | liver and spleen | .a | 1467 to 1827 | 372 to 7 | 366/375 (97 %) | 0 diff (100 %id) | ||
T99942 | liver and spleen | .a | 793 to 1076 | 1 to 286 | 286/389 (73 %) | 7 diff (98.3 %id) | ||
AA777658 | liver and spleen | .a | 1331 to 1826 | 496 to 1 | 496/496 (100 %) | 4 diff (99.2 %id) | ||
AA826691 | invasive tumor (cell line), Prostate | .a | 1399 to 1828 | 430 to 1 | 430/430 (100 %) | 3 diff (99.4 %id) | ||
AA827118 | germinal center B cell | .a | 4508 to 4899 | 412 to 21 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 392/392 (100 %) | 0 diff (100 %id) |
AA910049 | pooled | .a | 3781 to 4153 | 383 to 11 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 373/373 (100 %) | 0 diff (100 %id) |
AA927947 | pooled | .a | 3702 to 4130 | 429 to 1 | 429/429 (100 %) | 0 diff (100 %id) | ||
AA918543 | pooled | .a | 3012 to 3325 | 327 to 16 | AAA | 312/312 (100 %) | 2 diff (99.4 %id) | |
AA933921 | pooled | .a | 3207 to 3325 | 134 to 16 | AAA | 119/119 (100 %) | 0 diff (100 %id) | |
AI002323 | carcinoid, lung | .a | 3779 to 4127 | 349 to 1 | 349/349 (100 %) | 0 diff (100 %id) | ||
AI081790 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3650 to 4124 | 474 to 1 | 474/474 (100 %) | 2 diff (99.6 %id) | ||
AI123516 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 3611 to 4134 | 524 to 1 | tiling clone, | 524/524 (100 %) | 0 diff (100 %id) | |
AI218666 | .a | 3738 to 4128 | 415 to 25 | AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 391/391 (100 %) | 0 diff (100 %id) | |
AI363141 | anaplastic oligodendroglioma, brain | .a | 1403 to 1830 | 431 to 4 | 428/431 (99 %) | 0 diff (100 %id) | ||
AI364321 | anaplastic oligodendroglioma, brain | .a | 1380 to 1832 | 453 to 1 | 453/453 (100 %) | 0 diff (100 %id) | ||
AI570472 | anaplastic oligodendroglioma, brain | .a | 688 to 1151 | 464 to 1 | 464/464 (100 %) | 0 diff (100 %id) | ||
AI554630 | anaplastic oligodendroglioma, brain | .a | 1331 to 1830 | 504 to 5 | 500/504 (99 %) | 0 diff (100 %id) | ||
AI554695 | anaplastic oligodendroglioma, brain | .a | 1343 to 1830 | 492 to 5 | 488/492 (99 %) | 0 diff (100 %id) | ||
AI700755 | carcinoid, lung | .a | 3654 to 4131 | 478 to 1 | 478/478 (100 %) | 3 diff (99.4 %id) | ||
AI921106 | adenocarcinoma, Pancreas | .a | 1881 to 2354 | 474 to 1 | 474/474 (100 %) | 2 diff (99.6 %id) | ||
AI978684 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 1559 to 2081 | 524 to 1 | 524/527 (99 %) | 2 diff (99.7 %id) | ||
AI961947 | adenocarcinoma, Pancreas | .a | 3446 to 3815 | 371 to 2 | 370/371 (99 %) | 0 diff (100 %id) | ||
AW005174 | anaplastic oligodendroglioma, brain | .a | 616 to 1151 | 536 to 1 | 536/536 (100 %) | 0 diff (100 %id) | ||
AW591090 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 1997 to 2360 | 364 to 1 | 364/364 (100 %) | 2 diff (99.5 %id) | ||
AW614150 | Kidney | .a | 2965 to 3325 | 362 to 2 | 361/362 (99 %) | 0 diff (100 %id) | ||
BF513064 | .a | 4254 to 4899 | 663 to 18 | tiling clone, AAA | Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) | 646/646 (100 %) | 0 diff (100 %id) | |
BF510647 | .a | 3081 to 3325 | 262 to 18 | AAA | 245/245 (100 %) | 2 diff (99.2 %id) | ||
BQ027547 | mixed | .a | 3633 to 4123 | 509 to 19 | AAA | Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) | 491/491 (100 %) | 0 diff (100 %id) |
BF063144 | colon, colon tumor, RER+ | .a | 2817 to 3319 | 508 to 5 | 504/508 (99 %) | 3 diff (99.5 %id) | ||
BC017320 | Skin, melanotic melanoma. | .a | 42 to 1832 | 1 to 1791 | available from MGC, AAA | 1791/1791 (100 %) | 1 diff (100.0 %id) | |
BE277645 | melanotic melanoma, skin | .a | 42 to 533 | 26 to 516 | available from MGC, | 491/518 (94 %) | 8 diff (98.5 %id) | |
BC045106 | Uterus, endometrium adenocarcinoma | .a | 42 to 1832 | 1 to 1791 | available from MGC, AAA | 1791/1791 (100 %) | 1 diff (100.0 %id) | |
BE391746 | endometrium, adenocarcinoma cell line, uterus | .a | 42 to 642 | 26 to 626 | available from MGC, | 601/710 (84 %) | 9 diff (98.8 %id) | |
BE391563 | endometrium, adenocarcinoma cell line, uterus | .a | 42 to 642 | 43 to 642 | 600/768 (78 %) | 9 diff (98.9 %id) | ||
BC062352 | Skin, melanotic melanoma. | .a | 62 to 2327 | 1 to 2267 | available from MGC, AAA | 2267/2267 (100 %) | 4 diff (99.9 %id) | |
BE384665 | melanotic melanoma, skin | .a | 81 to 642 | 1 to 564 | available from MGC, | 564/765 (73 %) | 4 diff (99.5 %id) | |
BF433436 | carcinoid, lung | .a | 3513 to 3815 | 306 to 4 | 303/306 (99 %) | 0 diff (100 %id) | ||
BE895182 | melanotic melanoma, skin | .a | 3311 to 3825 | 1 to 514 | AAA | 514/514 (100 %) | 1 diff (99.9 %id) | |
BG107418 | Bone, osteosarcoma, cell line | .a | 3006 to 3822 | 1 to 814 | 814/886 (91 %) | 31 diff (96.6 %id) | ||
BC073884 | Bone, osteosarcoma | .a | 37 to 1826 | 1 to 1790 | available from MGC, AAA | 1790/1790 (100 %) | 0 diff (100 %id) | |
BG109617 | Bone, osteosarcoma, cell line | .a | 37 to 642 | 1 to 607 | available from MGC, | 607/669 (90 %) | 2 diff (99.8 %id) | |
BG106433 | lymph, lymphoma, cell line | .a | 2866 to 3657 | 1 to 786 | 786/796 (98 %) | 29 diff (96.4 %id) | ||
BF980500 | duodenal adenocarcinoma, cell line, small intestine | .a | 3057 to 3796 | 1 to 733 | 733/912 (80 %) | 11 diff (98.8 %id) | ||
BG250498 | adenocarcinoma, cell line, Liver | .a | 1880 to 2333 | 1 to 457 | 457/585 (78 %) | 5 diff (99.2 %id) | ||
BC024661 | Bladder, transitional cell papilloma | .a | 1533 to 2406 | 1 to 874 | AAA | 874/1143 (76 %) | 9 diff (99.3 %id) | |
BG260895 | bladder, transitional cell papilloma, cell line | .a | 1533 to 2334 | 1 to 801 | 801/975 (82 %) | 31 diff (96.9 %id) | ||
BC105593 | Testis, embryonal carcinoma | .a | 24 to 1059 | 1 to 1036 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1036/1060 (97 %) | 4 diff (99.7 %id) |
BG503224 | embryonal carcinoma, testis | .a | 27 to 642 | 1 to 617 | 617/713 (86 %) | 4 diff (99.5 %id) | ||
BC028077 | Blood, adult leukocytes | .a | 71 to 2327 | 1 to 2257 | available from MGC, AAA | 2257/2257 (100 %) | 3 diff (99.9 %id) | |
BI908126 | leukocyte | .a | 71 to 924 | 1 to 859 | available from MGC, | 859/859 (100 %) | 16 diff (98.2 %id) | |
BM904502 | leiomyosarcoma, uterus | .a | 3114 to 3984 | 1 to 878 | 878/1112 (78 %) | 34 diff (97.0 %id) | ||
BQ049213 | lymph, lymphoma, cell line | .a | 904 to 1887 | 40 to 1038 | 999/1047 (95 %) | 33 diff (96.9 %id) | ||
BQ230871 | epithelioid carcinoma, Pancreas | .a | 2532 to 3211 | 1 to 689 | 689/967 (71 %) | 19 diff (98.1 %id) | ||
BQ923868 | leiomyosarcoma, uterus | .a | 3607 to 4509 | 1 to 910 | tiling clone, | 910/912 (99 %) | 30 diff (96.8 %id) | |
CX165629 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 2924 to 3748 | 1 to 825 | tiling clone, | 825/825 (100 %) | 0 diff (100 %id) | |
CX871057 | embryonic stem | .a | 1682 to 2436 | 1 to 755 | tiling clone, | 755/755 (100 %) | 2 diff (99.8 %id) | |
CX755577 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 1027 to 1738 | 1 to 708 | Submitted on the opposite strand | 708/758 (93 %) | 6 diff (99.3 %id) | |
TI_57235495 | .a | 63 to 924 | 26 to 892 | 867/892 (97 %) | 23 diff (97.5 %id) | |||
CB118706 | Liver | .a | 489 to 1092 | 1 to 602 | 602/602 (100 %) | 2 diff (99.7 %id) | ||
NM_031923.2 | .a | 234 to 3023 | 1 to 2790 | RefSeq, | 2790/2790 (100 %) | 0 diff (100 %id) | ||
DA700284 | .a | 49 to 530 | 2 to 484 | capped | 483/483 (100 %) | 3 diff (99.4 %id) | ||
DA743721 | .a | 1 to 525 | 2 to 526 | tiling clone, capped | 525/525 (100 %) | 0 diff (100 %id) | ||
DA769109 | brain | .a | 50 to 556 | 2 to 508 | capped | 507/507 (100 %) | 0 diff (100 %id) | |
DA835937 | placenta | .a | 54 to 496 | 15 to 458 | capped | 444/444 (100 %) | 1 diff (99.8 %id) | |
CR992112 | T-Lymphocytes | .a | 105 to 1049 | 1 to 941 | 941/941 (100 %) | 6 diff (99.4 %id) | ||
DN992507 | brain, whole brain | .a | 92 to 749 | 1 to 657 | 657/657 (100 %) | 5 diff (99.3 %id) | ||
BM152698 | leukopheresis | .a | 42 to 300 | 1 to 259 | 259/259 (100 %) | 6 diff (97.7 %id) | ||
DB028381 | testis | .a | 51 to 593 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | |
DB046873 | testis | .a | 50 to 605 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |
DB059283 | testis | .a | 50 to 593 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | |
DB145297 | thymus | .a | 50 to 584 | 2 to 536 | capped | 535/535 (100 %) | 0 diff (100 %id) | |
DB205084 | trachea | .a | 50 to 641 | 2 to 593 | capped | 592/598 (98 %) | 1 diff (99.9 %id) | |
BM671518 | eye, Retina Foveal and Macular | .a | 3601 to 3814 | 232 to 19 | AAA | 214/214 (100 %) | 6 diff (97.2 %id) | |
BM704312 | eye, Retina Foveal and Macular | .a | 3004 to 3534 | 1 to 531 | 531/531 (100 %) | 0 diff (100 %id) | ||
BU625123 | cell lines, Enchondroma | .a | 2724 to 3325 | 620 to 19 | AAA | 602/602 (100 %) | 3 diff (99.6 %id) | |
BU618891 | Cell Line, Chondrosarcoma | .a | 1832 to 2375 | 544 to 2 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 543/544 (99 %) | 0 diff (100 %id) |
BP873338 | embryonal kidney | .a | 1533 to 2334 | 1 to 801 | This clone was ignored | 801/975 (82 %) | 31 diff (96.9 %id) | |
N70895 | lung | .a | 1533 to 2334 | 1 to 801 | 801/975 (82 %) | 31 diff (96.9 %id) | ||
W06920 | lung | .a | 24 to 1059 | 1 to 1036 | 1036/1060 (97 %) | 4 diff (99.7 %id) | ||
TI_149290943 | .a | 27 to 642 | 1 to 617 | AAA | This clone was ignored | 617/713 (86 %) | 4 diff (99.5 %id) | |
BU681978 | lung | .a | 27 to 642 | 1 to 617 | AAA | This clone was ignored | 617/713 (86 %) | 4 diff (99.5 %id) |
BC028077 | Blood, adult leukocytes | .a | 71 to 2327 | 1 to 2257 | available from MGC, AAA | 2257/2257 (100 %) | 3 diff (99.9 %id) | |
BI908126 | leukocyte | .a | 71 to 924 | 1 to 859 | available from MGC, | 859/859 (100 %) | 16 diff (98.2 %id) | |
BM904502 | leiomyosarcoma, uterus | .a | 3114 to 3984 | 1 to 878 | 878/1112 (78 %) | 34 diff (97.0 %id) | ||
BM904502 | leiomyosarcoma, uterus | .a | 3114 to 3984 | 1 to 878 | 878/1112 (78 %) | 34 diff (97.0 %id) | ||
BQ049213 | lymph, lymphoma, cell line | .a | 904 to 1887 | 40 to 1038 | 999/1047 (95 %) | 33 diff (96.9 %id) | ||
BQ049213 | lymph, lymphoma, cell line | .a | 904 to 1887 | 40 to 1038 | 999/1047 (95 %) | 33 diff (96.9 %id) | ||
BQ230871 | epithelioid carcinoma, Pancreas | .a | 2532 to 3211 | 1 to 689 | 689/967 (71 %) | 19 diff (98.1 %id) | ||
BQ230871 | epithelioid carcinoma, Pancreas | .a | 2532 to 3211 | 1 to 689 | 689/967 (71 %) | 19 diff (98.1 %id) | ||
BQ923868 | leiomyosarcoma, uterus | .a | 3607 to 4509 | 1 to 910 | tiling clone, | 910/912 (99 %) | 30 diff (96.8 %id) | |
BQ923868 | leiomyosarcoma, uterus | .a | 3607 to 4509 | 1 to 910 | tiling clone, | 910/912 (99 %) | 30 diff (96.8 %id) | |
CX165629 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 2924 to 3748 | 1 to 825 | tiling clone, | 825/825 (100 %) | 0 diff (100 %id) | |
CX871057 | embryonic stem | .a | 1682 to 2436 | 1 to 755 | tiling clone, | 755/755 (100 %) | 2 diff (99.8 %id) | |
CX755577 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 1027 to 1738 | 1 to 708 | Submitted on the opposite strand | 708/758 (93 %) | 6 diff (99.3 %id) | |
CX755577 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 1027 to 1738 | 1 to 708 | Submitted on the opposite strand | 708/758 (93 %) | 6 diff (99.3 %id) | |
TI_57235495 | .a | 63 to 924 | 26 to 892 | 867/892 (97 %) | 23 diff (97.5 %id) | |||
CB118706 | Liver | .a | 489 to 1092 | 1 to 602 | 602/602 (100 %) | 2 diff (99.7 %id) | ||
NM_031923.2 | .a | 234 to 3023 | 1 to 2790 | RefSeq, | 2790/2790 (100 %) | 0 diff (100 %id) | ||
DA700284 | .a | 49 to 530 | 2 to 484 | capped | 483/483 (100 %) | 3 diff (99.4 %id) | ||
DA743721 | .a | 1 to 525 | 2 to 526 | tiling clone, capped | 525/525 (100 %) | 0 diff (100 %id) | ||
DA769109 | brain | .a | 50 to 556 | 2 to 508 | capped | 507/507 (100 %) | 0 diff (100 %id) | |
DA835937 | placenta | .a | 54 to 496 | 15 to 458 | capped | 444/444 (100 %) | 1 diff (99.8 %id) | |
CR992112 | T-Lymphocytes | .a | 105 to 1049 | 1 to 941 | 941/941 (100 %) | 6 diff (99.4 %id) | ||
DN992507 | brain, whole brain | .a | 92 to 749 | 1 to 657 | 657/657 (100 %) | 5 diff (99.3 %id) | ||
DN992507 | brain, whole brain | .a | 92 to 749 | 1 to 657 | 657/657 (100 %) | 5 diff (99.3 %id) | ||
BM152698 | leukopheresis | .a | 42 to 300 | 1 to 259 | 259/259 (100 %) | 6 diff (97.7 %id) | ||
DB028381 | testis | .a | 51 to 593 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | |
DB046873 | testis | .a | 50 to 605 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |
DB059283 | testis | .a | 50 to 593 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | |
DB145297 | thymus | .a | 50 to 584 | 2 to 536 | capped | 535/535 (100 %) | 0 diff (100 %id) | |
DB205084 | trachea | .a | 50 to 641 | 2 to 593 | capped | 592/598 (98 %) | 1 diff (99.9 %id) | |
BM671518 | eye, Retina Foveal and Macular | .a | 3601 to 3814 | 232 to 19 | AAA | 214/214 (100 %) | 6 diff (97.2 %id) | |
BM671518 | eye, Retina Foveal and Macular | .a | 3601 to 3814 | 232 to 19 | AAA | 214/214 (100 %) | 6 diff (97.2 %id) | |
BM704312 | eye, Retina Foveal and Macular | .a | 3004 to 3534 | 1 to 531 | 531/531 (100 %) | 0 diff (100 %id) | ||
BM704312 | eye, Retina Foveal and Macular | .a | 3004 to 3534 | 1 to 531 | 531/531 (100 %) | 0 diff (100 %id) | ||
BU625123 | cell lines, Enchondroma | .a | 2724 to 3325 | 620 to 19 | AAA | 602/602 (100 %) | 3 diff (99.6 %id) | |
BU625123 | cell lines, Enchondroma | .a | 2724 to 3325 | 620 to 19 | AAA | 602/602 (100 %) | 3 diff (99.6 %id) | |
BU618891 | Cell Line, Chondrosarcoma | .a | 1832 to 2375 | 544 to 2 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 543/544 (99 %) | 0 diff (100 %id) |
BU618891 | Cell Line, Chondrosarcoma | .a | 1832 to 2375 | 544 to 2 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 543/544 (99 %) | 0 diff (100 %id) |